The domain within your query sequence starts at position 131 and ends at position 209; the E-value for the IGc1 domain shown below is 2.37e-14.

KSKLICEATNFTPKPITVSWLKDGKLVESGFTTDPVTIENKGSTPQTYKVISTLTISEID
WLNLNVYTCRVDHRGLTFL

IGc1

Immunoglobulin C-Type

• SMART accession number: SM00407
• Description: -
• Interpro abstract (IPR003597):

  The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 ), C1-set (constant-1; IPR003597 ), C2-set (constant-2; IPR008424 ) and I-set (intermediate; IPR013098 ) [ (PUBMED:9417933) ]. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [ (PUBMED:15327963) (PUBMED:11377196) ].

  Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system [ (PUBMED:10698639) ].

  This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [ (PUBMED:9597133) (PUBMED:12637770) ], and in various T-cell receptors.

There are 24638 IGc1 domains in 22657 proteins in SMART's nrdb database.

Disease (disease genes where sequence variants are found in this domain)

SwissProt sequences and OMIM curated human diseases associated with missense mutations within the IGc1 domain.

Protein	Disease
UNKNOWN (SMART)	OMIM:147020: Agammaglobulinemia OMIM:601495:
Immunoglobulin heavy constant gamma 2 (P01859) (SMART)	OMIM:147110: IgG2 deficiency, selective
Hereditary hemochromatosis protein (Q30201) (SMART)	OMIM:235200: Hemochromatosis ; Porphyria variegata OMIM:176200:

Metabolism (metabolic pathways involving proteins which contain this domain)

% proteins involved	KEGG pathway ID	Description
27.93	map04612	Antigen processing and presentation
26.28	map04940	Type I diabetes mellitus
26.28	map04514	Cell adhesion molecules (CAMs)
14.17	map04650	Natural killer cell mediated cytotoxicity
5.34	map04640	Hematopoietic cell lineage

This information is based on mapping of SMART genomic protein database to KEGG orthologous groups. Percentage points are related to the number of proteins with IGc1 domain which could be assigned to a KEGG orthologous group, and not all proteins containing IGc1 domain. Please note that proteins can be included in multiple pathways, ie. the numbers above will not always add up to 100%.

Structure (3D structures containing this domain)

3D Structures of IGc1 domains in PDB

PDB code	Title
1a1m	MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2
1a1n	MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1
1a1o	MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM
1a6a	THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
1a6z	HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
1a9b	DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1a9e	DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1adq	CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC
1agb	ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)
1agc	ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)
1agd	ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)
1age	ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)
1agf	ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)
1akj	COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
1ao7	COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201
1aqd	HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
1b0g	CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX
1b0r	CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP
1b3j	STRUCTURE OF THE MHC CLASS I HOMOLOG MIC-A, A GAMMADELTA T CELL LIGAND
1bd2	COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
1bii	THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110
1bmg	CRYSTAL STRUCTURE OF BOVINE BETA2-MICROGLOBULIN
1bqh	MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
1bx2	CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
1bz9	CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2-DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027
1c16	CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1cd1	CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
1ce6	MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE
1cg9	COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6
1cl7	ANTI HIV1 PROTEASE FAB
1cqk	CRYSTAL STRUCTURE OF THE CH3 DOMAIN FROM THE MAK33 ANTIBODY
1d5m	X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
1d5x	X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
1d5z	X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
1d6e	CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
1d9k	CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
1ddh	MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
1de4	HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
1dlh	CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
1dn2	FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2
1duy	CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
1duz	HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
1e27	Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM1(LPPVVAKEI)
1e28	Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM2(TAFTIPSI)
1e4k	Crystal structure of soluble human IgG1 Fc fragment-Fc-gamma Receptor III complex
1ed3	CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
1eey	Crystal Structure Determination Of HLA A2 Complexed to Peptide GP2 with the substitution (I2L/V5L/L9V)
1eez	Crystal Structure Determination of HLA-A2.1 Complexed to GP2 Peptide Variant(I2L/V5L)
1efx	STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1es0	CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
1exu	CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR
1f3j	HISTOCOMPATIBILITY ANTIGEN I-AG7
1f6a	Structure of the human ige-fc bound to its high affinity receptor fc(epsilon)ri(alpha)
1fc1	CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1fc2	CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION
1fcc	CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
1ffn	CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1ffo	CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1ffp	CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1fg2	CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1fne	HISTOCOMPATIBILITY ANTIGEN
1fng	HISTOCOMPATIBILITY ANTIGEN
1fo0	MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1fp5	CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN IGE-FC CEPSILON3-CEPSILON4 FRAGMENT.
1frt	CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1fv1	STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
1fyt	CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1
1fzj	MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1fzk	MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1fzm	MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1fzo	MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1g6r	A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1g7p	CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1g7q	CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA
1g84	THE SOLUTION STRUCTURE OF THE C EPSILON2 DOMAIN FROM IGE
1gzp	CD1b in complex with GM2 ganglioside
1gzq	CD1b in complex with Phophatidylinositol
1h15	X-ray crystal structure of HLA-DRA1*0101/DRB5*0101 complexed with a peptide from Epstein Barr Virus DNA polymerase.
1h3t	Crystal structure of the human igg1 fc-fragment,glycoform (mn2f)2
1h3u	Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
1h3v	Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
1h3w	Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
1h3x	Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
1h3y	Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
1hdm	HISTOCOMPATIBILITY ANTIGEN HLA-DM
1hhg	THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1hhh	THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1hhi	THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1hhj	THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1hhk	THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1hla	STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
1hoc	THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION
1hqr	CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH-AFFINITY, ZINC-DEPENDENT SITE ON MHC CLASS II
1hsa	THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1hsb	DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE
1hxy	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
1hyr	CRYSTAL STRUCTURE OF HUMAN MICA IN COMPLEX WITH NATURAL KILLER CELL RECEPTOR NKG2D
1i1a	CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
1i1c	NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A
1i1f	Crystal structure of human class i mhc (hla-a2.1) complexed with beta 2-microglobulin and hiv-rt variant peptide i1y
1i1y	CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1i3r	CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
1i4f	CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX
1i7r	CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
1i7t	CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
1i7u	CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
1iak	HISTOCOMPATIBILITY ANTIGEN I-AK
1iao	CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339
1iea	HISTOCOMPATIBILITY ANTIGEN
1ieb	HISTOCOMPATIBILITY ANTIGEN
1im3	Crystal Structure of the human cytomegalovirus protein US2 bound to the MHC class I molecule HLA-A2/tax
1im9	Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1 bound to its MHC ligand HLA-Cw4
1inq	Structure of Minor Histocompatibility Antigen peptide, H13a, complexed to H2-Db
1j8h	Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4
1je6	Structure of the MHC Class I Homolog MICB
1jf1	Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1/Melan-A
1jgd	HLA-B*2709 bound to deca-peptide s10R
1jge	HLA-B*2705 bound to nona-peptide m9
1jht	Crystal structure of HLA-A2*0201 in complex with a nonameric altered peptide ligand (ALGIGILTV) from the MART-1/Melan-A.
1jk8	Crystal structure of a human insulin peptide-HLA-DQ8 complex
1jl4	CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1jnj	NMR solution structure of the human beta2-microglobulin
1jpf	Crystal Structure Of The LCMV Peptidic Epitope Gp276 In Complex With The Murine Class I Mhc Molecule H-2Db
1jpg	Crystal Structure Of The LCMV Peptidic Epitope Np396 In Complex With The Murine Class I Mhc Molecule H-2Db
1juf	Structure of Minor Histocompatibility Antigen peptide, H13b, complexed to H2-Db
1jwm	Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1(HA peptide 306-318) with the Superantigen SEC3
1jws	Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the Superantigen SEC3 Variant 3B1
1jwu	Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the superantigen SEC3 Variant 3B2
1k2d	Crystal structure of the autoimmune MHC class II I-Au complexed with myelin basic protein 1-11 at 2.2A
1k5n	HLA-B*2709 BOUND TO NONA-PEPTIDE M9
1k8d	crystal structure of the non-classical MHC class Ib Qa-2 complexed with a self peptide
1k8i	CRYSTAL STRUCTURE OF MOUSE H2-DM
1kbg	MHC Class I H-2KB Presented Glycopeptide RGY8-6H-GAL2
1kg0	Structure of the Epstein-Barr Virus gp42 Protein Bound to the MHC class II Receptor HLA-DR1
1kgc	Immune Receptor
1kj2	Murine Alloreactive ScFv TCR-Peptide-MHC Class I Molecule Complex
1kj3	Mhc Class I H-2Kb molecule complexed with pKB1 peptide
1kjm	TAP-A-associated rat MHC class I molecule
1kjv	TAP-B-associated rat MHC class I molecule
1klg	Crystal structure of HLA-DR1/TPI(23-37, Thr28-->Ile mutant) complexed with staphylococcal enterotoxin C3 variant 3B2 (SEC3-3B2)
1klu	Crystal structure of HLA-DR1/TPI(23-37) complexed with staphylococcal enterotoxin C3 variant 3B2 (SEC3-3B2)
1kpr	The human non-classical major histocompatibility complex molecule HLA-E
1kpu	High resolution crystal structure of the MHC class I complex H-2Kb/VSV8
1kpv	High resolution crystal structure of the MHC class I complex H-2Kb/SEV9
1kt2	CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
1ktd	CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
1ktk	Complex of Streptococcal pyrogenic enterotoxin C (SpeC) with a human T cell receptor beta chain (Vbeta2.1)
1ktl	The human non-classical major histocompatibility complex molecule HLA-E
1l6x	FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
1ld9	THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1ldp	CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES
1lds	Crystal Structure of monomeric human beta-2-microglobulin
1leg	Crystal Structure of H-2Kb bound to the dEV8 peptide
1lek	Crystal Structure of H-2Kbm3 bound to dEV8
1lk2	1.35A crystal structure of H-2Kb complexed with the GNYSFYAL peptide
1lnu	CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAb BOUND TO EALPHA3K PEPTIDE
1lo5	Crystal structure of the D227A variant of Staphylococcal enterotoxin A in complex with human MHC class II
1lp9	Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1
1m05	HLA B8 in complex with an Epstein Barr Virus determinant
1m6o	Crystal Structure of HLA B*4402 in complex with HLA DPA*0201 peptide
1mhc	MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1mhe	THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1mi5	The crystal structure of LC13 TcR in complex with HLAB8-EBV peptide complex
1muj	Crystal structure of murine class II MHC I-Ab in complex with a human CLIP peptide
1mwa	2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1n2r	A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition.
1n3n	Crystal structure of a mycobacterial hsp60 epitope with the murine class I MHC molecule H-2Db
1n59	Crystal structure of the Murine class I Major Histocompatibility Complex of H-2KB, B2-Microglobulin, and A 9-Residue immunodominant peptide epitope gp33 derived from LCMV
1n5a	Crystal structure of the Murine class I Major Histocompatibility Complex of H-2DB, B2-Microglobulin, and A 9-Residue immunodominant peptide epitope gp33 derived from LCMV
1nam	MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1nan	MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
1nez	The Crystal Structure of a TL/CD8aa Complex at 2.1A resolution:Implications for Memory T cell Generation, Co-receptor Preference and Affinity
1nfd	AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
1ntl	Model of mouse Crry-Ig determined by solution scattering, curve fitting and homology modelling
1o0v	The crystal structure of IgE Fc reveals an asymmetrically bent conformation
1of2	Crystal structure of HLA-B*2709 complexed with the vasoactive intestinal peptide type 1 receptor (VIPR) peptide (residues 400-408)
1oga	A structural basis for immunodominant human T-cell receptor recognition.
1ogt	CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1onq	Crystal Structure of CD1a in Complex with a Sulfatide
1oqo	Complex between G0 version of an Fc bound to a minimized version of Protein A called Mini-Z
1oqx	G-2 glycovariant of human IgG Fc bound to minimized version of Protein A called Z34C
1osz	MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1ow0	Crystal structure of human FcaRI bound to IgA1-Fc
1p1z	X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2Kb
1p4l	Crystal structure of NK receptor Ly49C mutant with its MHC class I ligand H-2Kb
1p7q	Crystal Structure of HLA-A2 Bound to LIR-1, a Host and Viral MHC Receptor
1pfc	MOLECULAR-REPLACEMENT STRUCTURE OF GUINEA PIG IGG1 P*FC(PRIME) REFINED AT 3.1 ANGSTROMS RESOLUTION
1pqz	MURINE CYTOMEGALOVIRUS IMMUNOMODULATORY PROTEIN M144
1py4	Beta2 microglobulin mutant H31Y displays hints for amyloid formations
1pyw	Human class II MHC protein HLA-DR1 bound to a designed peptide related to influenza virus hemagglutinin, FVKQNA(MAA)AL, in complex with staphylococcal enterotoxin C3 variant 3B2 (SEC3-3B2)
1q94	Structures of HLA-A*1101 in complex with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle anchor residue
1qew	HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1qlf	MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
1qo3	Complex between NK cell receptor Ly49A and its MHC class I ligand H-2Dd
1qqd	CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
1qr1	POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1qrn	CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1qse	STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1qsf	STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1qvo	STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1r3h	Crystal Structure of T10
1r5i	Crystal structure of the MAM-MHC complex
1r5v	Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T-cell activation
1r5w	Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T-cell activation
1rjy	Mhc Class I Natural Mutant H-2Kbm8 Heavy Chain Complexed With beta-2 Microglobulin and Herpes Simplex Virus Glycoprotein B Peptide
1rjz	Mhc Class I Natural Mutant H-2Kbm8 Heavy Chain Complexed With beta-2 Microglobulin and Herpies Simplex Virus Mutant Glycoprotein B Peptide
1rk0	Mhc Class I H-2Kb Heavy Chain Complexed With beta-2 Microglobulin and Herpes Simplex Virus Glycoprotein B peptide
1rk1	Mhc Class I Natural H-2Kb Heavy Chain Complexed With beta-2 Microglobulin and Herpes Simplex Virus Mutant Glycoprotein B Peptide
1s7q	Crystal structures of the murine class I major histocompatibility complex H-2Kb in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7r	Crystal structures of the murine class I major histocompatibility complex H-2Kb in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7s	Crystal structures of the murine class I major histocompatibility complex H-2Kb in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7t	Crystal structures of the murine class I major histocompatibility complex H-2Kb in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7u	Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7v	Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7w	Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s7x	Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with LCMV-derived gp33 index peptide and three of its escape variants
1s8d	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3A
1s9v	Crystal structure of HLA-DQ2 complexed with deamidated gliadin peptide
1s9w	Crystal Structure Analysis of NY-ESO-1 epitope, SLLMWITQC, in complex with HLA-A2
1s9x	Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQA, in complex with HLA-A2
1s9y	Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQS, in complex with HLA-A2
1seb	COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1sje	HLA-DR1 complexed with a 16 residue HIV capsid peptide bound in a hairpin conformation
1sjh	HLA-DR1 complexed with a 13 residue HIV capsid peptide
1sys	Crystal structure of HLA, B*4403, and peptide EEPTVIKKY
1syv	HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF
1t0m	Conformational switch in polymorphic H-2K molecules containing an HSV peptide
1t0n	Conformational switch in polymorphic H-2K molecules containing an HSV peptide
1t1w	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3F6I8V
1t1x	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-4L
1t1y	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-5V
1t1z	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6A
1t20	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I
1t21	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, monoclinic crystal
1t22	Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, orthorhombic crystal
1t5w	HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR)
1t5x	HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) and the superantigen SEC3-3B2
1t7v	Zn-alpha-2-glycoprotein; baculo-ZAG PEG 200
1t7w	Zn-alpha-2-glycoprotein; CHO-ZAG PEG 400
1t7x	Zn-alpha-2-glycoprotein; refolded CHO-ZAG PEG 400
1t7y	Zn-alpha-2-glycoprotein; baculo-ZAG PEG 200, no glycerol
1t7z	Zn-alpha-2-glycoprotein; baculo-ZAG no PEG, no glycerol
1t80	Zn-alpha-2-glycoprotein; CHO-ZAG PEG 200
1t83	CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1t89	CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
1tmc	THE HTREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN
1tvb	Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2
1tvh	Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2
1u3h	Crystal structure of mouse TCR 172.10 complexed with MHC class II I-Au molecule at 2.4 A
1u58	Crystal structure of the murine cytomegalovirus MHC-I homolog m144
1uqs	The Crystal Structure of Human CD1b with a Bound Bacterial Glycolipid
1uvq	Crystal structure of HLA-DQ0602 in complex with a hypocretin peptide
1uxs	CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS
1uxw	CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
1vac	MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN
1vad	MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1vgk	The crystal structure of class I Major histocompatibility complex, H-2Kd at 2.0 A resolution
1w0v	Crystal Structure Of HLA-B*2705 Complexed With the self-Peptide TIS from EGF-response factor 1
1w0w	Crystal Structure Of HLA-B*2709 Complexed With the self-Peptide TIS from EGF-response factor 1
1w72	Crystal structure of HLA-A1:MAGE-A1 in complex with Fab-Hyb3
1wbx	CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 Db AND Kb MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1wby	CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 Db AND Kb MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1wbz	CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 Db AND Kb MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1x7q	Crystal structure of HLA-A*1101 with sars nucleocapsid peptide
1xh3	Conformational Restraints and Flexibility of 14-Meric Peptides in Complex with HLA-B*3501
1xr8	Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus EBNA-3
1xr9	Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus EBNA-3
1xz0	Crystal structure of CD1a in complex with a synthetic mycobactin lipopeptide
1ydp	1.9A crystal structure of HLA-G
1ymm	TCR/HLA-DR2b/MBP-peptide complex
1yn6	Crystal structure of a mouse MHC class I protein, H2-Db, in complex with a peptide from the influenza A acid polymerase
1yn7	Crystal structure of a mouse MHC class I protein, H2-Db, in complex with a mutated peptide (R7A) of the influenza A acid polymerase
1ypz	Immune receptor
1z5l	Structure of a highly potent short-chain galactosyl ceramide agonist bound to CD1D
1zag	HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
1zgl	Crystal structure of 3A6 TCR bound to MBP/HLA-DR2a
1zhb	Crystal Structure Of The Murine Class I Major Histocompatibility Complex Of H-2Db, B2-Microglobulin, and a 9-Residue Peptide Derived from rat dopamine beta-monooxigenase
1zhk	Crystal structure of HLA-B*3501 presenting 13-mer EBV antigen LPEPLPQGQLTAY
1zhl	Crystal structure of HLA-B*3508 presenting 13-mer EBV antigen LPEPLPQGQLTAY
1zhn	Crystal Structure of mouse CD1d bound to the self ligand phosphatidylcholine
1zs8	Crystal Structure of the Murine MHC Class Ib Molecule M10.5
1zsd	Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY
1zt1	crystal structure of class I MHC H-2Kk in complex with an octapeptide
1zt4	The crystal structure of human CD1d with and without alpha-Galactosylceramide
1zt7	crystal structure of class I MHC H-2Kk in complex with a nonapeptide
1zvs	Crystal structure of the first class MHC mamu and Tat-Tl8 complex
2a83	Crystal structure of hla-b*2705 complexed with the glucagon receptor (gr) peptide (residues 412-420)
2ak4	Crystal Structure of SB27 TCR in complex with HLA-B*3508-13mer peptide
2akr	Structural basis of sulfatide presentation by mouse CD1d
2aty	Complement receptor chimaeric conjugate CR2-Ig
2av1	Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the E63Q and K66A mutations in the heavy chain.
2av7	Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the K66A mutation in the heavy chain.
2axf	The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation
2axg	The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation
2axh	Crystal structures of T cell receptor beta chains related to rheumatoid arthritis
2axj	Crystal structures of T cell receptor beta chains related to rheumatoid arthritis
2bc4	Crystal structure of HLA-DM
2bck	Crystal Structure of HLA-A*2402 Complexed with a telomerase peptide
2bnq	Structural and kinetic basis for heightened immunogenicity of T cell vaccines
2bnr	Structural and kinetic basis for heightened immunogenicity of T cell vaccines
2bnu	Structural and kinetic basis for heightened immunogenicity of T cell vaccines
2bsr	Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B2705
2bss	Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B2705
2bst	Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B2705
2bvo	Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Non-Progression
2bvp	Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Non-Progression
2bvq	Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Non-Progression
2c7u	Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant HIV epitope.
2cde	Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide specific T cell receptors - iNKT-TCR
2cdf	Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T cell receptors (TCR 5E)
2cdg	Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T cell receptors (TCR 5B)
2cii	The crystal structure of H-2Db complexed with a partial peptide epitope suggests an MHC Class I assembly-intermediate
2cik	Insights Into Crossreactivity in Human Allorecognition: The Structure of HLA-B35011 Presenting an Epitope derived from Cytochrome P450.
2ckb	STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2clr	THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
2clv	MHC Class I Natural Mutant H-2Kbm8 Heavy Chain Complexed With beta-2 Microglobulin and pBM8 peptide
2clz	Mhc Class I Natural Mutant H-2Kbm8 Heavy Chain Complexed With beta-2 Microglobulin and pBM1 peptide
2d31	Crystal structure of disulfide-linked HLA-G dimer
2d4d	The Crystal Structure of human beta2-microglobulin, L39W W60F W95F Mutant
2d4f	The Crystal Structure of human beta2-microglobulin
2dts	Crystal Structure of the Defucosylated Fc Fragment from Human Immunoglobulin G1
2dyp	Crystal Structure of LILRB2(LIR2/ILT4/CD85d) complexed with HLA-G
2esv	Structure of the HLA-E-VMAPRTLIL/KK50.4 TCR complex
2eyr	A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
2eys	A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
2eyt	A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
2f53	Directed Evolution of Human T-cell Receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without apparent cross-reactivity
2f54	Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity
2f74	Murine MHC class I H-2Db in complex with human b2-microglobulin and LCMV-derived immunodminant peptide gp33
2f8o	A Native to Amyloidogenic Transition Regulated by a Backbone Trigger
2fik	Structure of a microbial glycosphingolipid bound to mouse CD1d
2fo4	Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumor associated MUC1-8 peptide
2fse	Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen
2fwo	MHC Class I H-2Kd heavy chain in complex with beta-2microglobulin and peptide derived from influenza nucleoprotein
2fyy	The role of T cell receptor alpha genes in directing human MHC restriction
2fz3	The role of T cell receptor alpha genes in directing human MHC restriction
2g9h	Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human MHC class II Molecule
2gaz	Mycobacterial lipoglycan presentation by CD1d
2git	Human Class I MHC HLA-A2 in complex with the modified HTLV-1 TAX (Y5K-4-[3-Indolyl]-butyric acid) peptide
2gj6	The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5K-4-[3-Indolyl]-butyric acid) peptide
2gj7	Crystal Structure of a gE-gI/Fc complex
2gt9	Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide
2gtw	Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L substitution
2gtz	Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L substitution
2guo	Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide
2h26	human CD1b in complex with endogenous phosphatidylcholine and spacer
2h32	Crystal structure of the pre-B cell receptor
2h3n	Crystal structure of a surrogate light chain (LAMBDA5 and VpreB) homodimer
2h6p	Crystal structure of HLA-B*3501 presenting the human cytochrome P450 derived peptide, KPIVVLHGY
2hjk	Crystal Structure of HLA-B5703 and HIV-1 peptide
2hjl	Crystal Structure of HLA-B5703 and HIV-1 peptide
2hla	SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68
2hn7	HLA-A*1101 in complex with HBV peptide homologue
2iad	CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138
2ial	Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR
2iam	Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR
2ian	Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR
2icw	Crystal structure of a complete ternary complex between TCR, superantigen, and peptide-MHC class II molecule
2ipk	Crystal Structure of the MHC Class II Molecule HLA-DR1 in Complex with the Fluorogenic Peptide, AcPKXVKQNTLKLAT (X=3-[5-(dimethylamino)-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl]-L-alanine) and the Superantigen, SEC3 Variant 3B2
2iwg	COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2j6e	Crystal Structure of an Autoimmune Complex between a Human IgM Rheumatoid Factor and IgG1 Fc reveals a Novel Fc Epitope and Evidence for Affinity Maturation
2j8u	Large CDR3a loop alteration as a function of MHC mutation.
2jcc	AH3 recognition of mutant HLA-A2 W167A
2mha	CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
2nna	Structure of the MHC class II molecule HLA-DQ8 bound with a deamidated gluten peptide
2nts	Crystal Structure of SEK-hVb5.1
2nw3	Crystal structure of HLA-B*3508 presenting EBV peptide EPLPQGQLTAY at 1.7A
2nx5	Crystal structure of ELS4 TCR bound to HLA-B*3501 presenting EBV peptide EPLPQGQLTAY at 1.7A
2oje	Mycoplasma arthritidis-derived mitogen complexed with class II MHC molecule HLA-DR1/HA complex in the presence of EDTA
2ol3	crystal structure of BM3.3 ScFV TCR in complex with PBM8-H-2KBM8 MHC class I molecule
2p24	I-Au/MBP125-135
2p5e	Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Binding Geometry
2p5w	Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal binding geometry
2po6	Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and NKT15 Beta-Chain
2pxy	Crystal structures of immune receptor complexes
2pye	Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Binding Geometry TCR Clone C5C1 Complexed with MHC
2pyf	Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Binding Geometry Unbound TCR Clone 5-1
2q6w	The structure of HLA-DRA, DRB3*0101 (DR52a) with bound platelet integrin peptide associated with fetal and neonatal alloimmune thrombocytopenia
2q7y	Structure of the endogenous iNKT cell ligand iGb3 bound to mCD1d
2qej	Crystal structure of a Staphylococcus aureus protein (SSL7) in complex with Fc of human IgA1
2ql1	Structural Characterization of a Mutated, ADCC-Enhanced Human Fc Fragment
2qri	Crystal structure of a single chain trimer composed of the MHC I heavy chain H-2Kb WT, beta-2microglobulin, and ovalbumin-derived peptide.
2qrs	Crystal Structure of a single chain trimer composed of the MHC I heavy chain H-2Kb Y84A, beta-2microglobulin, and ovalbumin-derived peptide.
2qrt	Crystal Structure of a disulfide trapped single chain trimer composed of the MHC I heavy chain H-2Kb Y84C, beta-2microglobulin, and ovalbumin-derived peptide.
2rcj	Solution structure of human Immunoglobulin M
2rfx	Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF
2rgs	FC-fragment of monoclonal antibody IGG2B from Mus musculus
2seb	X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
2uwe	Large CDR3a loop alteration as a function of MHC mutation
2v2w	T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
2v2x	T cell cross-reactivity and conformational changes during TCR engagement.
2vaa	MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
2vab	MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
2vb5	Solution structure of W60G mutant of human beta2-microglobulin
2ve6	Crystal structure of a Murine MHC class I H2-Db molecule in complex with a photocleavable peptide
2vlj	The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its Vbeta Domain
2vlk	The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its Vbeta Domain
2vll	The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its Vbeta Domain
2vlm	The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its Vbeta Domain
2vlr	The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its Vbeta Domain
2vuo	Crystal structure of the rabbit IgG Fc fragment
2w59	Structure of an Avian IgY-Fc 3-4 Fragment
2wah	Crystal Structure of an IgG1 Fc Glycoform (Man9GlcNAc2)
2wbj	TCR complex
2wng	complete extracellular structure of human signal regulatory protein ( SIRP) alpha
2wqr	The high resolution crystal structure of IgE Fc
2wy3	Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands
2x4n	Crystal structure of MHC CLass I HLA-A2.1 bound to residual fragments of a photocleavable peptide that is cleaved upon UV-light treatment
2x4o	Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 envelope peptide env120-128
2x4p	Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide
2x4q	Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide
2x4r	Crystal structure of MHC CLass I HLA-A2.1 bound to Cytomegalovirus ( CMV) pp65 epitope
2x4s	Crystal structure of MHC CLass I HLA-A2.1 bound to a peptide representing the epitope of the H5N1 (Avian Flu) Nucleoprotein
2x4t	Crystal structure of MHC CLass I HLA-A2.1 bound to a Peiodate- cleavable peptide
2x4u	Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476
2x70	Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide
2x89	Structure of the Beta2_microglobulin involved in amyloidogenesis
2xfx	cattle MHC class I N01301 presenting an 11mer from Theileria parva
2xks	Prion-like conversion during amyloid formation at atomic resolution
2xku	Prion-like conversion during amyloid formation at atomic resolution
2xn9	Crystal structure of the ternary complex between human T cell receptor, staphylococcal enterotoxin H and human major histocompatibility complex class II
2xna	Crystal structure of the complex between human T cell receptor and staphylococcal enterotoxin
2xpg	Crystal structure of a MHC class I-peptide complex
2xtj	The crystal structure of PCSK9 in complex with 1D05 Fab
2y7q	The high-affinity complex between IgE and its receptor Fc epsilon RI
2yez	COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
2ypk	Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms
2ypl	Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms
2yxf	The high resolution crystal structure of beta2-microglobulin under physiological conditions
2z31	Crystal structure of immune receptor complex
2z9t	Crystal structure of the human beta-2 microglobulin mutant W60G
2zok	Crystal structure of H-2Db in complex with JHMV epitope S510
2zol	Crystal structure of H-2Db in complex with the W513S variant of JHMV epitope S510
2zsv	Crystal structure of H-2Kb in complex with JHMV epitope S598
2zsw	Crystal structure of H-2Kb in complex with the Q600Y variant of JHMV epitope S598
3agv	Crystal structure of a human IgG-aptamer complex
3am8	Crystal Structure of a Human Major Histocompatibilty complex
3arb	Ternary crystal structure of the NKT TCR-CD1d-alpha-galactosylceramide analogue-OCH
3ard	Ternary crystal structure of the mouse NKT TCR-CD1d-3'deoxy-alpha-galactosylceramide
3are	Ternary crystal structure of the mouse NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide
3arf	Ternary crystal structure of the mouse NKT TCR-CD1d-C20:2
3arg	Ternary crystal structure of the mouse NKT TCR-CD1d-alpha-glucosylceramide(C20:2)
3au1	Crystal structure of mouse CD1d in complex with ganglioside GD3
3ave	Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1
3ay4	Crystal structure of nonfucosylated Fc complexed with bis-glycosylated soluble form of Fc gamma receptor IIIa
3b3i	Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes
3b6s	Crystal Structure of hla-b*2705 Complexed with the Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (vipr) Peptide (residues 400-408)
3bev	11mer Structure of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding
3bew	10mer Crystal Structure of chicken MHC class I haplotype B21
3bgm	Crystal Structure of PKD2 Phosphopeptide Bound to Human Class I MHC HLA-A2
3bh8	Crystal Structure of RQA_M Phosphopeptide Bound to HUMAN Class I MHC HLA-A2
3bh9	Crystal Structure of RTY Phosphopeptide Bound to Human Class I MHC HLA-A2
3bhb	Crystal Structure of KMD Phosphopeptide Bound to Human Class I MHC HLA-A2
3bo8	The High Resolution Crystal Structure of HLA-A1 Complexed with the MAGE-A1 Peptide
3bp4	The high resolution crystal structure of HLA-B*2705 in complex with a Cathepsin A signal sequence peptide pCatA
3bp7	The high resolution crystal structure of HLA-B*2709 in complex with a Cathepsin A signal sequence peptide, pCatA
3buy	MHC-I in complex with peptide
3bvn	High resolution crystal structure of HLA-B*1402 in complex with the latent membrane protein 2 peptide (LMP2) of Epstein-Barr virus
3bw9	Crystal Structure of HLA B*3508 in complex with a HCMV 12-mer peptide from the pp65 protein
3bwa	Crystal Structure of HLA B*3508 in complex with a HCMV 8-mer peptide from the pp65 protein
3bxn	The high resolution crystal structure of HLA-B*1402 complexed with a Cathepsin A signal sequence peptide, pCatA
3bze	The human non-classical major histocompatibility complex molecule HLA-E
3bzf	The human non-classical major histocompatibility complex molecule HLA-E
3c2s	Structural Characterization of a Human Fc Fragment Engineered for Lack of Effector Functions
3c5j	Crystal structure of HLA DR52c
3c5z	Crystal structure of mouse MHC class II I-Ab/3K peptide complexed with mouse TCR B3K506
3c60	Crystal structure of mouse MHC class II I-Ab/3K peptide complexed with mouse TCR YAe62
3c6l	Crystal structure of mouse MHC class II I-Ab/3K peptide complexed with mouse TCR 2W20
3c8k	The crystal structure of Ly49C bound to H-2Kb
3c9n	Crystal Structure of a SARS Corona Virus Derived Peptide Bound to the Human Major Histocompatibility Complex Class I molecule HLA-B*1501
3cc5	H-2Db complex with human gp100
3cch	H-2Db complex with murine gp100
3cdg	Human CD94/NKG2A in complex with HLA-E
3ch1	Crystal structure of H-2Db in complex with chimeric gp100
3cii	Structure of NKG2A/CD94 bound to HLA-E
3ciq	A regulatable switch mediates self-association in an immunoglobulin fold
3cpl	Crystal Structure of H-2Db in complex with a variant M6A of the NP366 peptide from influenza A virus
3cup	Crystal structure of the MHC class II molecule I-Ag7 in complex with the peptide GAD221-235
3cvh	How TCR-like antibody recognizes MHC-bound peptide
3czf	Crystal structure of HLA-B*2709 complexed with the glucagon receptor (GR) peptide (residues 412-420)
3d18	Crystal structure of HLA-B*2709 complexed with a variant of the latent membrane protein 2 peptide (LMP2(L)) of epstein-barr virus
3d25	Crystal structure of HA-1 minor histocompatibility antigen bound to human class I MHC HLA-A2
3d2u	Structure of UL18, a Peptide-Binding Viral MHC Mimic, Bound to a Host Inhibitory Receptor
3d39	The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(4-fluoroPhenylalanine)) peptide
3d3v	The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(3,4-difluoroPhenylalanine)) peptide
3d6g	Fc fragment of IgG1 (Herceptin) with protein-A mimetic peptide dendrimer ligand.
3dbx	Structure of chicken CD1-2 with bound fatty acid
3dhj	Beta 2 microglobulin mutant W60C
3dhm	Beta 2 microglobulin mutant D59P
3dmm	Crystal structure of the CD8 alpha beta/H-2Dd complex
3dnk	Enzyme deglycosylated Human IgG1 Fc fragment
3do3	Human 1gG1 Fc fragment, 2.5 Angstrom structure
3dtx	Crystal structure of HLA-B*2705 complexed with the double citrullinated vasoactive intestinal peptide type 1 receptor (VIPR) peptide (residues 400-408)
3dx6	Crystal Structure of B*4402 presenting a 10mer EBV epitope
3dx7	Crystal Structure of HLA-B*4403 presenting 10mer EBV antigen
3dx8	Crystal Structure of B*4405 presenting a 10mer EBV epitope
3dx9	Crystal Structure of the DM1 TCR at 2.75A
3dxa	Crystal Structure of the DM1 TCR in complex with HLA-B*4405 and decamer EBV antigen
3e6f	MHC CLASS I H-2Dd Heavy chain complexed with Beta-2 Microglobulin and a variant peptide, PA9, from the Human immunodeficiency virus (BaL) envelope glycoprotein 120
3e6h	MHC CLASS I H-2Dd heavy chain complexed with Beta-2 Microglobulin and a variant peptide, PI10, from the human immunodeficiency virus (BaL) envelope glycoprotein 120
3ecb	Crystal structure of mouse H-2Dd in complex with peptide P18-I10 derived from human immunodeficiency virus envelope glycoprotein 120
3ekc	structure of W60V beta-2 microglobulin mutant
3es6	Crystal structure of the novel complex formed between Zinc 2-glycoprotein (ZAG) and Prolactin inducible protein (PIP) from human seminal plasma
3ffc	Crystal Structure of CF34 TCR in complex with HLA-B8/FLR
3fjt	Crystal structure of a human Fc fragment engineered for extended serum half-life
3fol	Crystal structure of the Class I MHC Molecule H-2Kwm7 with a Single Self Peptide VNDIFERI
3fom	Crystal structure of the Class I MHC Molecule H-2Kwm7 with a Single Self Peptide IQQSIERL
3fon	Crystal structure of the Class I MHC Molecule H-2Kwm7 with a Single Self Peptide VNDIFEAI
3fqn	Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes
3fqr	Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes
3fqt	Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes
3fqu	Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes
3fqw	Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes
3fqx	Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presentation and generates tumor specific epitopes
3fru	NEONATAL FC RECEPTOR, PH 6.5
3ft2	Crystal Structure of a citrulline peptide variant of the minor histocompatibility peptide HA-1 in complex with HLA-A2
3ft3	Crystal Structure of the minor histocompatibility peptide HA-1His in complex with HLA-A2
3ft4	Crystal Structure of the minor histocompatibility peptide HA-1Arg in complex with HLA-A2
3ftg	Crystal Structure of H2Db in complex with NP366-N3A variant peptide from influenza
3g08	Crystal structure of the alpha-galactosylceramide analog OCH in complex with mouse CD1d
3gbl	Crystal structure of grass carp Beta2-microglobulin
3giv	Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
3gjf	Rational development of high-affinity T-cell receptor-like antibodies
3gml	Structure of mouse CD1d in complex with C6Ph
3gmm	Structure of mouse CD1d in complex with C8Ph
3gmn	Structure of mouse CD1d in complex with C10Ph
3gmo	Structure of mouse CD1d in complex with C8PhF
3gmp	Structure of mouse CD1d in complex with PBS-25
3gmq	Structure of mouse CD1d expressed in SF9 cells, no ligand added
3gmr	Structure of mouse CD1d in complex with C8Ph, different space group
3gsn	Crystal structure of the public RA14 TCR in complex with the HCMV dominant NLV/HLA-A2 epitope
3gso	Crystal structure of the binary complex between HLA-A2 and HCMV NLV peptide
3gsq	Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5S peptide variant
3gsr	Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5V peptide variant
3gsu	Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5T peptide variant
3gsv	Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5Q peptide variant
3gsw	Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8A peptide variant
3gsx	Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8V peptide variant
3h7b	Human Class I MHC HLA-A2 in complex with the Tel1p peptide
3h9h	Human Class I MHC HLA-A2(A150P) in complex with the Tel1p peptide
3h9s	The complex between TCR A6 and human Class I MHC HLA-A2 with the bound Tel1p peptide
3h9y	Crystal structure of the IgE-Fc3-4 domains
3h9z	Crystal structure of the IgE-Fc3-4 domains
3ha0	Crystal structure of the IgE-Fc3-4 domains
3hae	Rational development of high-affinity T-cell receptor-like antibodies
3hcv	Crystal structure of HLA-B*2709 complexed with the double citrullinated vasoactive intestinal peptide type 1 receptor (VIPR) peptide (residues 400-408)
3he6	Crystal structure of mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta8.2 NKT TCR
3he7	Crystal structure of mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta7 NKT TCR
3hg1	Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor
3hkf	Murine unglycosylated IgG Fc fragment
3hla	SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68
3hpj	Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) peptide
3huj	Crystal structure of human CD1d-alpha-Galactosylceramide in complex with semi-invariant NKT cell receptor
3i6g	Newly identified epitope Mn2 from SARS-CoV M protein complexed withHLA-A*0201
3i6k	Newly identified epitope from SARS-CoV membrane protein complexed with HLA-A*0201
3i6l	Newly identified epitope N1 derived from SARS-CoV N protein complexed with HLA-A*2402
3ib4	The double mutant of Beta-2 microglobulin K58P-W60G
3ilp	Structure of mCD1d with bound glycolipid BbGL-2f from Borrelia burgdorferi
3ilq	Structure of mCD1d with bound glycolipid BbGL-2c from Borrelia burgdorferi
3ixa	Human Class I MHC HLA-A2(A150P) in complex with the Tax peptide
3jts	GY9-Mamu-A*02-hb2m
3jtt	Cystal structure of Rhesus macaque MHC class I:Mamu-A*02
3jvg	Crystal Structure of chicken CD1-1
3kla	Ca2+ release from the endoplasmic reticulum of NY-ESO-1 specific T cells is modulated by the affinity of T cell receptor and by the use of the CD8 co-receptor
3kpl	Crystal Structure of HLA B*4402 in complex with EEYLQAFTY a self peptide from the ABCD3 protein
3kpm	Crystal Structure of HLA B*4402 in complex with EEYLKAWTF, a mimotope
3kpn	Crystal Structure of HLA B*4403 in complex with EEYLQAFTY a self peptide from the ABCD3 protein
3kpo	Crystal Structure of HLA B*4403 in complex with EEYLKAWTF, a mimotope
3kpp	Crystal Structure of HLA B*4405 in complex with EEYLQAFTY a self peptide from the ABCD3 protein
3kpq	Crystal Structure of HLA B*4405 in complex with EEYLKAWTF, a mimotope
3kpr	Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF a mimotope
3kps	Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY a self peptide from the ABCD3 protein
3kww	Crystal structure of the 'restriction triad' mutant of HLA B*3508, beta-2-microglobulin and EBV peptide
3kxf	Crystal Structure of SB27 TCR in complex with the 'restriction triad' mutant HLA-B*3508-13mer
3kyn	Crystal structure of HLA-G presenting KGPPAALTL peptide
3kyo	Crystal structure of HLA-G presenting KLPAQFYIL peptide
3l3d	Crystal structure of HLA-B*4402 in complex with the F3A mutant of a self-peptide derived from DPA*0201
3l3g	Crystal structure of HLA-B*4402 in complex with the R5A mutant of a self-peptide derived from DPA*0201
3l3h	X-ray crystal structure of the F6A mutant of influenza A acid polymerase epitope PA224 bound to murine H2-Db MHC
3l3i	Crystal structure of HLA-B*4402 in complex with the F7A mutant of a self-peptide derived from DPA*0201
3l3j	Crystal structure of HLA-B*4402 in complex with the F3A/R5A double mutant of a self-peptide derived from DPA*0201
3l3k	Crystal structure of HLA-B*4402 in complex with the R5A/F7A double mutant of a self-peptide derived from DPA*0201
3l6f	Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1
3l9r	Crystal structure of bovine CD1b3 with endogenously bound ligands
3lkn	Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1918 strain
3lko	Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1934 strain
3lkp	Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1972 strain
3lkq	Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1977 strain
3lkr	Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 2009 H1N1 swine origin strain
3lks	Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1980 strain
3ln4	Crystal structure of HLA-B*4103 in complex with a 16mer self-peptide derived from heterogeneous nuclear ribonucleoproteins C1/C2
3ln5	Crystal structure of HLA-B*4104 in complex with a 11mer self-peptide derived from S-methyl-5-thioadenosine phosphorylase
3low	Crystal structure of Beta 2 Microglobulin domain-swapped dimer
3lqz	Crystal Structure of HLA-DP2
3lv3	Crystal structure of HLA-B*2705 complexed with a peptide derived from the human voltage-dependent calcium channel alpha1 subunit (residues 513-521)
3m17	Crystal structure of human FcRn with a monomeric peptide inhibitor
3m1b	Crystal structure of human FcRn with a dimeric peptide inhibitor
3ma7	Crystal structure of Cardiolipin bound to mouse CD1D
3mbe	TCR 21.30 in complex with MHC class II I-Ag7HEL(11-27)
3mff	1F1E8hu TCR
3mgo	Crystal structure of a H5-specific CTL epitope derived from H5N1 influenza virus in complex with HLA-A*0201
3mgt	Crystal structure of a H5-specific CTL epitope variant derived from H5N1 influenza virus in complex with HLA-A*0201
3mr9	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide M5A variant
3mrb	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide A7H variant
3mrc	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6C variant
3mrd	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6G variant
3mre	Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide
3mrf	Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide T4P variant
3mrg	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide
3mrh	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide N3S variant
3mri	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide G4M-V5W variant
3mrj	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide V5M variant
3mrk	Crystal Structure of MHC class I HLA-A2 molecule complexed with AFP137 nonapeptide
3mrl	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide C6V variant
3mrm	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1406-1415 decapeptide
3mrn	Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS4b-1807-1816 decapeptide
3mro	Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant
3mrp	Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant
3mrq	Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant
3mrr	Crystal Structure of MHC class I HLA-A2 molecule complexed with Human Prostaglandin Transporter decapeptide
3mv7	Crystal Structure of the TK3 TCR in complex with HLA-B*3501/HPVG
3mv8	Crystal Structure of the TK3-Gln55His TCR in complex with HLA-B*3501/HPVG
3mv9	Crystal Structure of the TK3-Gln55Ala TCR in complex with HLA-B*3501/HPVG
3myj	Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) (R1Y) peptide variant.
3myz	Protein induced photophysical changes to the amyloid indicator dye, thioflavin T
3mzt	Protein-induced photophysical changes to the amyloid indicator dye, thioflavin T
3na4	D53P beta-2 microglobulin mutant
3nfn	Recognition of peptide-MHC by a V-delta/V-beta TCR
3nwm	Crystal structure of a single chain construct composed of MHC class I H-2Kd, beta-2microglobulin and a peptide which is an autoantigen for type 1 diabetes
3o3a	Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1
3o3b	Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1.1
3o3d	Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2
3o3e	Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2.1
3o4l	Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus
3o6f	Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4
3o81	Beta2-microglobulin from Gallus gallus
3o8x	Recognition of Glycolipid Antigen by iNKT Cell TCR
3o9w	Recognition of a Glycolipid Antigen by the iNKT Cell TCR
3of6	Human pre-T cell receptor crystal structure
3ov6	CD1c in complex with MPM (mannosyl-beta1-phosphomycoketide)
3ox8	Crystal Structure of HLA A*02:03 Bound to HBV Core 18-27
3oxr	Crystal Structure of HLA A*02:06 Bound to HBV Core 18-27
3oxs	Crystal Structure of HLA A*02:07 Bound to HBV Core 18-27
3p4m	Crystal Structure of H2-Kb in complex with the NP205-LCMV epitope YTVKYPNL, an 8-mer peptide from the LCMV
3p4n	Crystal Structure of H2-Kb in complex with the NP205-PV epitope YTVKFPNM, an 8-mer peptide from PV
3p4o	Crystal Structure of H2-Kb in complex with the mutant NP205-LCMV-V3A epitope YTAKYPNL, an 8-mer modified peptide from the LCMV
3p73	Crystal Structures of the Chicken YF1*7.1 molecule
3p77	Crystal Structures of the Chicken YF1*7.1 molecule
3p9l	Crystal Structure of H2-Kb in complex with the chicken ovalbumin epitope OVA
3p9m	Crystal Structure of H2-Kb in complex with a mutant of the chicken ovalbumin epitope OVA-G4
3pab	Crystal Structure of H2-Kb in complex with a mutant of the chicken ovalbumin epitope OVA-E1
3pdo	Crystal Structure of HLA-DR1 with CLIP102-120
3pgc	Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation
3pgd	Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation
3pl6	Structure of Autoimmune TCR Hy.1B11 in complex with HLA-DQ1 and MBP 85-99
3pqy	Crystal Structure of 6218 TCR in complex with the H2Db-PA224
3pv6	Crystal structure of NKp30 bound to its ligand B7-H6
3pv7	Crystal structure of NKp30 ligand B7-H6
3pwj	Human Class I MHC HLA-A2 in complex with the HuD (G2L,I9V) peptide variant
3pwl	Human Class I MHC HLA-A2 in complex with the HuD peptide
3pwn	Human Class I MHC HLA-A2 in complex with the HuD (G2L) peptide variant
3pwp	The complex between TCR A6 and human Class I MHC HLA-A2 with the bound HuD peptide
3pwu	An immmunodominant CTL epitope from rinderpest virus presented by cattle MHC class I molecule N*01801(BoLA-A11)
3pwv	An immmunodominant CTL epitope from rinderpest virus presented by cattle MHC class I molecule N*01801 (BoLA-A11)
3q5t	V beta/V beta homodimerization-based pre-TCR model suggested by TCR beta crystal structures
3q5y	V beta/V beta homodimerization-based pre-TCR model suggested by TCR beta crystal structures
3qda	Crystal structure of W95L beta-2 microglobulin
3qdg	The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) peptide
3qdj	The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric peptide
3qdm	The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decameric peptide
3qeq	The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric peptide
3qeu	The crystal structure of TCR DMF5
3qfd	Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide
3qfj	The complex between TCR A6 and human Class I MHC HLA-A2 with the modified TAX (Y5F) peptide
3qh3	The crystal structure of TCR A6
3qi9	Crystal structure of mouse CD1d-alpha-phosphotidylinositol with mouse Valpha14-Vbeta6 2A3-D NKT TCR
3qib	Crystal structure of the 2B4 TCR in complex with MCC/I-Ek
3qiu	Crystal structure of the 226 TCR in complex with MCC/I-Ek
3qiw	Crystal structure of the 226 TCR in complex with MCC-p5E/I-Ek
3qjf	Crystal structure of the 2B4 TCR
3qjh	The crystal structure of the 5c.c7 TCR
3qq3	Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides
3qq4	Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides
3quk	Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with LCMV-derived gp33 altered peptide ligand (Y4A)
3qul	Crystal structures of the murine class I major histocompatibility complex H-2Db in complex with LCMV-derived gp33 altered peptide ligand (Y4S)
3qux	Structure of the mouse CD1d-alpha-C-GalCer-iNKT TCR complex
3quy	Structure of the mouse CD1d-BnNH-GSL-1'-iNKT TCR complex
3quz	Structure of the mouse CD1d-NU-alpha-GalCer-iNKT TCR complex
3qxa	HLA-DR1 bound with CLIP peptide
3qxd	F54C HLA-DR1 bound with CLIP peptide
3qzw	Plasticity of human CD8 binding to peptide-HLA-A*2402
3rdt	Crystal Structure of 809.B5 TCR complexed with MHC Class II I-Ab/3k peptide
3rev	Crystal structure of human alloreactive tcr nb20
3rew	Crystal structure of an lmp2a-derived peptide bound to human class i mhc hla-a2
3rgv	A single TCR bound to MHCI and MHC II reveals switchable TCR conformers
3rl1	HIV RT derived peptide complexed to HLA-A*0301
3rl2	HIV Nef derived peptide Nef73 complexed to HLA-A*0301
3rol	Murine class I major histocompatibility complex H-2Kb in complex with post-translationally modified LCMV-derived gp34-41 peptide, comprising a nitrotyrosine at position 3
3roo	Murine class I major histocompatibility complex H-2Kb in complex with immunodominant LCMV-derived gp34-41 peptide
3rtq	Structure of the mouse CD1d-HS44-iNKT TCR complex
3rug	Crystal structure of Valpha10-Vbeta8.1 NKT TCR in complex with CD1d-alphaglucosylceramide (C20:2)
3rwc	Crystal structure of rhesus macaque MHC class I molecule Mamu-B*17-IW9
3rwd	rhesus macaque MHC class I molecule Mamu-B*17-IW11
3rwe	rhesus macaque MHC class I molecule Mamu-B*17-FW9
3rwf	Rhesus macaque MHC class I molecule Mamu-B*17-QW9
3rwg	Rhesus macaque MHC class I molecule Mamu-B*17-MW9
3rwh	Rhesus macaque MHC class I molecule Mamu-B*17-MF8
3rwi	Rhesus macaque MHC class I molecule Mamu-B*17-GW10
3rwj	Rhesus macaque MHC class I molecule Mamu-B*17-HW8
3ry6	Complex of fcgammariia (CD32) and the FC of human IGG1
3rzc	Structure of the self-antigen iGb3 bound to mouse CD1d and in complex with the iNKT TCR
3s4s	Crystal structure of CD4 mutant bound to HLA-DR1
3s5l	Crystal structure of CD4 mutant bound to HLA-DR1
3s6c	Structure of human CD1e
3s7g	Aglycosylated human igg1 fc fragment
3scm	Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-isoglobotrihexosylceramide
3sda	Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-beta-galactosylceramide
3sdc	Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-globotrihexosylceramide
3sdd	Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-beta-lactosylceramide
3sdx	Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylceramide
3sgj	Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgIII and antibodies lacking core fucose
3sgk	Unique carbohydrate/carbohydrate interactions are required for high affinity binding of FcgIII and antibodies lacking core fucose
3sjv	Crystal structure of the RL42 TCR in complex with HLA-B8-FLR
3skm	Crystal structure of the HLA-B8FLRGRAYVL, mutant G8V of the FLR peptide
3skn	Crystal structure of the RL42 TCR unliganded
3sko	Crystal structure of the HLA-B8-A66-FLR, mutant A66 of the HLA B8
3spv	Crystal structure of a peptide-HLA complex
3t0e	Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4
3t1f	Crystal structure of the mouse CD1d-Glc-DAG-s2 complex
3t8x	Crystal structure of human CD1b in complex with synthetic antigenic diacylsulfoglycolipid SGL12 and endogenous spacer
3ta3	Structure of the mouse CD1d-Glc-DAG-s2-iNKT TCR complex
3tbs	CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE ligand (V3P,Y4A)
3tbt	CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE ligand (V3P, Y4S)
3tbv	CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE ligand (A2G,V3P,Y4A)
3tbw	CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE ligand (A2G, V3P, Y4S)
3tby	CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE ligand (V3P, Y4F)
3tid	Crystal structure of the LCMV derived peptide GP34 in complex with the murine mhc class I H-2 Kb
3tie	Crystal structure of the vaccinia derived peptide A11R in complex with the murine MHC CLASS I H-2 KB
3tlr	Crystal Structure of the tetrameric Beta-2 microglobulin DIMC20 mutant
3tm6	Crystal structure of the beta-2 microglobulin DIMC50 disulphide-linked homodimer mutant
3tn0	Structure of mouse Va14Vb8.2NKT TCR-mouse CD1d-a-C-Galactosylceramide complex
3to2	Structure of HLA-A*0201 complexed with peptide Md3-C9 derived from a clustering region of restricted cytotoxic T lymphocyte epitope from SARS-CoV M protein
3to4	Structure of mouse Valpha14Vbeta2-mouseCD1d-alpha-Galactosylceramide
3tvm	Structure of the mouse CD1d-SMC124-iNKT TCR complex
3tyf	Crystal structure of a CD1d-lysophosphatidylcholine reactive iNKT TCR
3tzv	Crystal structure of an iNKT TCR in complex with CD1d-lysophosphatidylcholine
3u0p	Crystal structure of human CD1d-lysophosphatidylcholine
3ubx	Crystal structure of the mouse CD1d-C20:2-aGalCer-L363 mAb Fab complex
3upr	HLA-B*57:01 complexed to pep-V and Abacavir
3utp	1E6 TCR specific for HLA-A*0201-ALWGPDPAAA
3utq	Human HLA-A*0201-ALWGPDPAAA
3uts	1E6-A*0201-ALWGPDPAAA Complex, Monoclinic
3utt	1E6-A*0201-ALWGPDPAAA Complex, Triclinic
3v5d	HLA-A2.1 KVAELVHFL
3v5h	HLA-A2.1 KVAEIVHFL
3v5k	HLA2.1 KVAELVWFL
3v7m	Crystal structure of monoclonal human anti-Rhesus D Fc IgG1 T125(YB2/0) in the presence of Zn2+
3v8c	Crystal structure of monoclonal human anti-rhesus D Fc IgG1 t125(yb2/0) double mutant (H310 and H435 in K)
3v95	Crystal structure of monoclonal human anti-rhesus D Fc and IgG1 t125(yb2/0) in the presence of EDTA
3vcl	Crystal Structure of HLA-B7 with the HCMV pp65 peptide RPHERNGFTVL
3vfm	crystal structure of HLA B*3508 LPEP155A, HLA mutant Ala155
3vfn	crystal structure of HLA B*3508LPEP151A, HLA mutant Ala151
3vfo	crystal structure of HLA B*3508 LPEP157A, HLA mutant Ala157
3vfp	crystal structure of HLA B*3508 LPEP158G, HLA mutant Gly158
3vfr	crystal structure of HLA B*3508LPEP-P4Ala, peptide mutant P4-ala
3vfs	crystal structure of HLA B*3508LPEP-P5Ala , peptide mutant P5-ala
3vft	crystal structure of HLA B*3508LPEP-P6Ala, peptide mutant P6-ala
3vfu	crystal structure of HLA B*3508 LPEP-P7Ala, peptide mutant P7-ala
3vfv	crystal structure of HLA B*3508 LPEP-P9Ala, peptide mutant P9-ala
3vfw	crystal structure of HLA B*3508 LPEP-P10Ala, peptide mutant P10-ala
3vh8	KIR3DL1 in complex with HLA-B*5701
3vj6	Structure of the MHC class Ib molecule Qa-1b
3vri	HLA-B*57:01-RVAQLENVYI in complex with abacavir
3vrj	HLA-B*57:01-LTTKLTNTNI in complex with abacavir
3vwj	Ternary crystal structure of the human NKT TCR-CD1d-C20:2 complex
3vwk	Ternary crystal structure of the human NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide complex
3vxm	The complex between C1-28 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide
3vxn	HLA-A24 in complex with HIV-1 Nef134-10(wt)
3vxo	HLA-A24 in complex with HIV-1 Nef134-10(2F)
3vxp	HLA-A24 in complex with HIV-1 Nef134-10(6L)
3vxq	H27-14 TCR specific for HLA-A24-Nef134-10
3vxr	The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(wt) peptide
3vxs	The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(6L) peptide
3vxt	T36-5 TCR specific for HLA-A24-Nef134-10
3vxu	The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide
3w0w	The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide in space group P212121
3w39	Crystal structure of HLA-B*5201 in complexed with HIV immunodominant epitope (TAFTIPSI)
3wex	3WEX
3wjj	Crystal structure of IIb selective Fc variant, Fc(P238D), in complex with FcgRIIb
3wjl	Crystal structure of IIb selective Fc variant, Fc(V12), in complex with FcgRIIb
3wkn	3WKN
3wl9	3WL9
3wlb	3WLB
3wn5	3WN5
3ws3	Crystal Structure of H-2D in complex with an insulin derived peptide
3ws6	Crystal Structure of H-2D in complex with a mimotopic peptide
3wuw	3WUW
3x11	3X11
3x12	3X12
3x13	3X13
3x14	3X14
3zo0	Mouse IgG2a in complex with mouse TRIM21 PRYSPRY
4acp	Deactivation of human IgG1 Fc by endoglycosidase treatment
4aen	HLA-DR1 with covalently linked CLIP106-120 in reversed orientation
4ah2	HLA-DR1 with covalently linked CLIP106-120 in canonical orientation
4apq	Crystal structure of autoreactive-Valpha14-Vbeta6 NKT TCR in complex with CD1d-sulfatide
4b53	Crystal structure of the isolated IgG4 CH3 domain
4b7i	Crystal Structure of Human IgG Fc Bearing Hybrid-type Glycans
4bm7	Crystal Structure of IgG Fc F241A mutant with native glycosylation
4bsv	Heterodimeric Fc Antibody Azymetric Variant 1
4bsw	Heterodimeric Fc Antibody Azymetric Variant 2
4byh	Crystal structure of sialylated IgG Fc
4c54	Crystal structure of recombinant human IgG4 Fc
4c55	Crystal structure of serum-derived human IgG4 Fc
4c56	4C56
4cdh	4CDH
4cvx	4CVX
4cvz	4CVZ
4cw1	4CW1
4d0b	4D0B
4d0c	4D0C
4d0d	4D0D
4d2n	4D2N
4d8p	Structural and functional studies of the trans-encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) molecule
4dz8	human IgG1 Fc fragment Heterodimer
4dzb	Mucosal-associated invariant T cell receptor, Valpha7.2Jalpha33-Vbeta2
4e0r	Structure of the chicken MHC class I molecule BF2*0401
4e41	Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor G4
4e42	Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor G4
4e5x	Crystal structure of a complex between the human adenovirus type 2 E3-19K protein and MHC class I molecule HLA-A2/Tax
4ei5	Crystal Structure of XV19 TCR in complex with CD1d-sulfatide C24:1
4ei6	Structure of XV19 Valpha1-Vbeta16 Type-II Natural Killer T cell receptor
4elk	Crystal structure of the Hy19.3 type II NKT TCR
4elm	Crystal structure of the mouse CD1d-lysosulfatide-Hy19.3 TCR complex
4en3	Crystal structure of a human Valpha24(-) NKT TCR in complex with CD1d/alpha-galactosylceramide
4eup	The complex between TCR JKF6 and human Class I MHC HLA-A2 presenting the MART-1(27-35)(A27L) peptide
4ezm	Crystal structure of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23
4f7c	Crystal structure of bovine CD1d with bound C12-di-sulfatide
4f7e	Crystal structure of bovine CD1d with bound C16:0-alpha-galactosyl ceramide
4f7m	Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PA (649-658)
4f7p	Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009H1N1 PB1 (496-505)
4f7t	Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PB1 (498-505)
4fqx	Crystal structure of HLA-DM bound to HLA-DR1
4ftv	The complex between the high affinity version of A6 TCR (A6c134) and human Class I MHC HLA-A2 with the bound TAX nonameric peptide
4fxl	Crystal structure of the D76N Beta-2 Microglobulin mutant
4g42	Structure of the Chicken MHC Class I Molecule BF2*0401 complexed to pepitde P8D
4g43	Structure of the chicken MHC class I molecule BF2*0401 complexed to P5E
4g8e	Crystal Structure of clone18 TCR
4g8f	Crystal Structure of clone42 TCR
4g8g	Crystal Structure of C12C TCR-HA B2705-KK10
4g8i	Crystal Structure of HLA B2705-KK10-L6M
4g9d	Crystal Structure of HLA B2705-KK10
4g9f	Crystal Structure of C12C TCR-HLAB2705-KK10-L6M
4gbx	Crystal structure of an immune complex at pH 6.5
4gg6	Protein complex
4gg8	Immune Receptor
4gkn	A2-MHC Complex carrying FATGIGIITV
4gko	Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23
4gks	A2-MHC Complex carrying FLTGIGIITV
4gkz	HA1.7, a MHC class II restricted TCR specific for haemagglutinin
4grg	Crystal structure of IgE complexed with E2_79, an anti-IgE inhibitor
4grl	Crystal structure of a autoimmune TCR-MHC complex
4grm	The crystal structure of the high affinity TCR A6
4gt7	An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, non-receptor binding conformation
4gup	Structure of MHC-class I related molecule MR1
4h1l	TCR interaction with peptide mimics of nickel offers structural insights in nickel contact allergy
4h25	TCR interaction with peptide mimics of nickel offers structure insights to nickel contact allergy
4h26	TCR interaction with peptide mimics of nickel offers structure insight to nickel contact allergy
4haf	Crystal structure of fc-fragment of human IgG2 antibody (primitive crystal form)
4hag	Crystal structure of fc-fragment of human IgG2 antibody (centered crystal form)
4hkj	Structure of Cowpox CPXV203 in complex with MHCI (H-2Kb)
4hs3	Crystal structure of H-2Kb with a disulfide stabilized F pocket in complex with the LCMV derived peptide GP34
4huu	Crystal Structure of H2Db-NPM6I
4huv	Crystal Structure of H2Db-NPM6W
4huw	Crystal Structure of H2Db-NPM6T
4hux	Crystal Structure of H2Db-H155A-NP
4hv8	Crystal Structure of H2Db-H155A-NPM6I
4hwz	Structure of HLA-A68 complexed with an HIV derived peptide
4hx1	Structure of HLA-A68 complexed with a tumor antigen derived peptide
4i0p	HLA-DO in complex with HLA-DM
4i2x	Crystal structure of Signal Regulatory Protein gamma (SIRP-gamma) in complex with FabOX117
4i48	Structure of HLA-A68 complexed with an HIV Env derived peptide
4i4w	Peptide length determines the outcome of T cell receptor/peptide-MHCI engagement
4i5b	Structure of human MHC class II protein HLA-DR1 carrying an influenza hemagglutinin peptide partially filling the binding groove
4iho	Crystal structure of H-2Db Y159F in complex with chimeric gp100
4iiq	Crystal structure of a human MAIT TCR in complex with bovine MR1
4irj	Structure of the mouse CD1d-4ClPhC-alpha-GalCer-iNKT TCR complex
4irs	Structure of the mouse CD1d-PyrC-alpha-GalCer-iNKT TCR complex
4is6	Crystal structure of HLA-DR4 bound to GP100 peptide
4j12	monomeric Fc
4j4p	The complex of human IgE-Fc with two bound Fab fragments
4jfd	Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a melanoma-specific TCR
4jfe	Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a melanoma-specific TCR
4jff	Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a melanoma-specific TCR
4jfh	High Affinity alpha24-beta17 T Cell Receptor for A2 HLA-Melanoma peptide complex
4jfo	A2 HLA complex with E1A heteroclitic variant of Melanoma peptide
4jfp	A2 HLA complex with G4A heteroclitic variant of Melanoma peptide
4jfq	A2 HLA complex with L8A heteroclitic variant of Melanoma peptide
4jqv	HLA-B*18:01 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 173-180)
4jqx	HLA-B*44:03 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 169-180)
4jrx	Crystal Structure of CA5 TCR-HLA B*3505-LPEP complex
4jry	Crystal Structure of SB47 TCR-HLA B*3505-LPEP complex
4jvu	IgM C2-domain from mouse
4jvw	IgM C4-domain from mouse
4k71	Crystal structure of a high affinity Human Serum Albumin variant bound to the Neonatal Fc Receptor
4k7f	Newly identified epitope V60 from HBV core protein complexed with HLA-A*0201
4kdt	Structure of an early native-like intermediate of beta2-microglobulin amyloidosis
4ki1	Primitive triclinic crystal form of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23
4ku1	Role of the hinge and C-gamma-2/C-gamma-3 interface in immunoglobin G1 Fc domain motions: implications for Fc engineering
4l29	Structure of wtMHC class I with NY-ESO1 double mutant
4l3c	Structure of HLA-A2 in complex with D76N b2m mutant and NY-ESO1 double mutant
4l3e	4L3E
4l4j	Crystal structure of fc-fragment of human IgG2-Sigma antibody
4l4t	Structure of human MAIT TCR in complex with human MR1-6-FP
4l4v	Structure of human MAIT TCR in complex with human MR1-RL-6-Me-7-OH
4l8b	Crystal structure of the H2Db in complex with the NP-N5H peptide
4l8c	Crystal structure of the H2Db in complex with the NP-N3D peptide
4l8d	Crystal structure of the H2Db in complex with the NP-N5D peptide
4l8s	Crystal structure of a human Valpha7.2/Vbeta13.3 MAIT TCR in complex with bovine MR1
4l9l	Crystal structure of a human Valpha7.2/Vbeta13.2 MAIT TCR in complex with bovine MR1
4lcc	Crystal structure of a human MAIT TCR in complex with a bacterial antigen bound to humanized bovine MR1
4lcw	The structure of human MAIT TCR in complex with MR1-K43A-RL-6-Me-7OH
4lcy	4LCY
4lfh	Crystal Structure of 9C2 TCR
4lhu	Crystal Structure of 9C2 TCR bound to CD1d
4lld	Structure of wild-type IgG1 antibody heavy chain constant domain 1 and light chain lambda constant domain (IgG1 CH1:Clambda) at 1.19A
4llm	Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 1, CRD1) at 1.75A
4llq	Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 2 beta, CRD2b) at 1.42A
4lnr	4LNR
4m8v	4M8V
4m9o	4M9O
4may	Crystal structure of an immune complex
4mcy	Immune Receptor
4mcz	Immune Receptor
4md0	Immune Receptor
4md4	Immune Receptor
4md5	Immune Receptor
4mdi	Immune Receptor
4mdj	Immune Receptor
4mj5	4MJ5
4mj6	4MJ6
4mji	4MJI
4mng	Structure of the DP10.7 TCR with CD1d-sulfatide
4mnh	Structure of the DP10.7 TCR
4mnq	TCR-peptide specificity overrides affinity enhancing TCR-MHC interactions
4mq7	Structure of human CD1d-sulfatide
4mx7	4MX7
4n0f	Human FcRn complexed with human serum albumin
4n0u	Ternary complex between Neonatal Fc receptor, serum albumin and Fc
4n8v	Crystal structure of killer cell immunoglobulin-like receptor KIR2DS2 in complex with HLA-A
4ndm	Structure of the AB18.1 TCR
4nhg	Crystal Structure of 2G12 IgG Dimer
4nhh	Structure of 2G12 IgG Dimer
4nnx	4NNX
4nny	4NNY
4no0	4NO0
4no2	4NO2
4no3	4NO3
4no5	4NO5
4nqc	Crystal structure of TCR-MHC ternary complex and covalently bound 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil
4nqd	Crystal structure of TCR-MHC ternary complex and non-covalently bound 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil
4nqe	Crystal structure of TCR-MHC ternary complex bound to 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil
4nqs	Knob-into-hole IgG Fc
4nqt	anti-parallel Fc-hole(T366S/L368A/Y407V) homodimer
4nqu	anti-parallel Fc-knob (T366W) homodimer
4nqv	Crystal Structure of HLA A*0101 in complex with NP44, an 9-mer influenza epitope
4nqx	Crystal Structure of HLA A*0101 in complex with NP44-S7N, an 9-mer influenza epitope
4nsk	CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE ligand V3P
4nt6	4NT6
4o2c	4O2C
4o2e	4O2E
4o2f	4O2F
4onh	4ONH
4ono	4ONO
4ov5	4OV5
4ozf	JR5.1 protein complex
4ozg	D2 protein complex
4ozh	S16 protein complex
4ozi	S2 protein complex
4p23	4P23
4p2o	Crystal structure of the 2B4 TCR in complex with 2A/I-Ek
4p2q	Crystal structure of the 5cc7 TCR in complex with 5c2/I-Ek
4p2r	Crystal structure of the 5cc7 TCR in complex with 5c1/I-Ek
4p46	4P46
4p4k	4P4K
4p4r	4P4R
4p57	4P57
4p5k	4P5K
4p5m	4P5M
4p5t	4P5T
4pg2	4PG2
4pg9	4PG9
4pgb	4PGB
4pgc	4PGC
4pgd	4PGD
4pge	4PGE
4pj5	4PJ5
4pj7	4PJ7
4pj8	4PJ8
4pj9	4PJ9
4pja	4PJA
4pjb	4PJB
4pjc	4PJC
4pjd	4PJD
4pje	4PJE
4pjf	4PJF
4pjg	4PJG
4pjh	4PJH
4pji	4PJI
4pjx	4PJX
4pr5	Crystal structure of a HLA-B*35:01-HPVG-D5
4pra	Crystal structure of a HLA-B*35:01-HPVG-Q5
4prb	Crystal structure of a HLA-B*35:08-HPVG-A4
4prd	Crystal structure of a HLA-B*35:08-HPVG-D5
4pre	Crystal structure of a HLA-B*35:08-HPVG-Q5
4prh	Crystal structure of TK3 TCR-HLA-B*35:08-HPVG-D5 complex
4pri	Crystal structure of TK3 TCR-HLA-B*35:08-HPVG complex
4prn	Crystal structure of a HLA-B*35:01-HPVG-A4
4prp	Crystal structure of TK3 TCR-HLA-B*35:01-HPVG-Q5 complex
4pv8	Crystal Structure of H2Kb-Q600F complex
4pv9	Crystal Structure of H2Kb-Q600V complex
4q6y	4Q6Y
4q74	4Q74
4q7d	4Q7D
4q97	4Q97
4q9b	4Q9B
4q9c	4Q9C
4qgt	4QGT
4qok	4QOK
4qrp	4QRP
4qrq	4QRQ
4qrr	4QRR
4qrs	4QRS
4qrt	4QRT
4qru	4QRU
4r9h	4R9H
4ra3	4RA3
4rah	4RAH
4rmq	4RMQ
4rmr	4RMR
4rms	4RMS
4rmt	4RMT
4rmu	4RMU
4rmv	4RMV
4rmw	4RMW
4u1h	4U1H
4u1i	4U1I
4u1j	4U1J
4u1k	4U1K
4u1l	4U1L
4u1m	4U1M
4u1n	4U1N
4u1s	4U1S
4u6x	4U6X
4u6y	4U6Y
4udt	4UDT
4udu	4UDU
4uq2	4UQ2
4uq3	4UQ3
4w4n	4W4N
4w4o	4W4O
4wdi	4WDI
4wi2	4WI2
4wi3	4WI3
4wi4	4WI4
4wi5	4WI5
4wi6	4WI6
4wi7	4WI7
4wi8	4WI8
4wi9	4WI9
4wj5	4WJ5
4wnq	4WNQ
4wo4	4WO4
4wu5	4WU5
4wu7	4WU7
4wuu	4WUU
4ww1	4WW1
4ww2	4WW2
4wwi	4WWI
4wwk	4WWK
4x4m	4X4M
4x5w	4X5W
4x5x	4X5X
4x6b	4X6B
4x6c	4X6C
4x6d	4X6D
4x6e	4X6E
4x6f	4X6F
4x98	4X98
4x99	4X99
4xxc	4XXC
4y16	4Y16
4y19	4Y19
4y1a	4Y1A
4y2d	4Y2D
4y4f	4Y4F
4y4h	4Y4H
4y4k	4Y4K
4z76	4Z76
4z77	4Z77
4z78	4Z78
4z7u	4Z7U
4z7v	4Z7V
4z7w	4Z7W
4zak	4ZAK
4zdh	4ZDH
4zez	4ZEZ
4zfz	4ZFZ
4znc	4ZNC
4zne	4ZNE
4zso	4ZSO
4zus	4ZUS
4zut	4ZUT
4zuu	4ZUU
4zuv	4ZUV
4zuw	4ZUW
5acz	5ACZ
5ad0	5AD0
5anm	5ANM
5b38	5B38
5b39	5B39
5brz	5BRZ
5bs0	5BS0
5bw7	5BW7
5bxf	5BXF
5c07	5C07
5c08	5C08
5c09	5C09
5c0a	5C0A
5c0b	5C0B
5c0c	5C0C
5c0d	5C0D
5c0e	5C0E
5c0f	5C0F
5c0g	5C0G
5c0h	5C0H
5c0i	5C0I
5c0j	5C0J
5c9j	5C9J
5cfh	5CFH
5cka	5CKA
5ckg	5CKG
5cnz	5CNZ
5cs7	5CS7
5csb	5CSB
5csg	5CSG
5d2l	5D2L
5d2n	5D2N
5d4q	5D4Q
5d5m	5D5M
5d6d	5D6D
5d7i	5D7I
5d7j	5D7J
5d7k	5D7K
5d7l	5D7L
5d9s	5D9S
5ddh	5DDH
5def	5DEF
5deg	5DEG
5di8	5DI8
5dj0	5DJ0
5dj2	5DJ2
5dj6	5DJ6
5dj8	5DJ8
5dja	5DJA
5djc	5DJC
5djd	5DJD
5djx	5DJX
5djy	5DJY
5djz	5DJZ
5dk0	5DK0
5dk2	5DK2
5dmk	5DMK
5dvk	5DVK
5dvl	5DVL
5dvm	5DVM
5dvn	5DVN
5dvo	5DVO
5e6i	5E6I
5e8n	5E8N
5e8o	5E8O
5e8p	5E8P
5e9d	5E9D
5efi	5EFI
5enw	5ENW
5eo0	5EO0
5eo1	5EO1
5eu3	5EU3
5eu4	5EU4
5eu5	5EU5
5eu6	5EU6
5euo	5EUO
5f1i	5F1I
5f1n	5F1N
5fk9	5FK9
5fka	5FKA
5fkp	5FKP
5h94	5H94
5hga	5HGA
5hgb	5HGB
5hgd	5HGD
5hgh	5HGH
5hhm	5HHM
5hhn	5HHN
5hho	5HHO
5hhp	5HHP
5hhq	5HHQ
5hsf	5HSF
5hvw	5HVW
5hyj	5HYJ
5hys	5HYS
5im7	5IM7
5inc	5INC
5ind	5IND
5iro	5IRO
5j1a	5J1A
5j6g	5J6G
5j6h	5J6H
5ks9	5KS9
5ksa	5KSA
5ksb	5KSB
5l2j	5L2J
5l2k	5L2K
5swq	5SWQ
5sws	5SWS
5swz	5SWZ

Links (links to other resources describing this domain)

• INTERPRO: IPR003597
• PFAM: ig
• PROSITE: IG_MHC